$GILD GILEAD SCIENCES INC Insider Trading Week 10/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC in week 10/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 21.58 | 16,728 | 360,907 | 7,904 | |
| Mar 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.32 | 16,728 | 1,326,833 | 28,562 | 45.3 K to 28.6 K (-36.94 %) |
| Mar 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 21.58 | 16,728 | 360,907 | 45,290 | 28.6 K to 45.3 K (+58.57 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 79.92 | 40,180 | 3,211,186 | 86,652 | 126.8 K to 86.7 K (-31.68 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 77,000 | 0 | 126,832 | 49.8 K to 126.8 K (+154.52 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 79.92 | 54,790 | 4,378,817 | 119,302 | 174.1 K to 119.3 K (-31.47 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 105,000 | 0 | 174,092 | 69.1 K to 174.1 K (+151.97 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 21.94 | 968 | 21,243 | 69,092 | 68.1 K to 69.1 K (+1.42 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Payment of Exercise | F | 79.92 | 187,848 | 15,012,812 | 4,429,387 | 4.6 M to 4.4 M (-4.07 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 360,000 | 0 | 4,617,235 | 4.3 M to 4.6 M (+8.46 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 79.92 | 11,280 | 901,498 | 28,562 | 39.8 K to 28.6 K (-28.31 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 0.00 | 24,000 | 0 | 39,842 | 15.8 K to 39.8 K (+151.50 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Payment of Exercise | F | 79.92 | 82,968 | 6,630,803 | 938,048 | 1 M to 938 K (-8.13 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Grant | A | 0.00 | 159,000 | 0 | 1,021,016 | 862 K to 1 M (+18.45 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Grant | A | 21.94 | 968 | 21,243 | 862,016 | 861 K to 862 K (+0.11 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Payment of Exercise | F | 79.92 | 54,790 | 4,378,817 | 134,694 | 189.5 K to 134.7 K (-28.92 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Grant | A | 0.00 | 105,000 | 0 | 189,484 | 84.5 K to 189.5 K (+124.28 %) |